DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-804 Cr |
| Mar2024 | ₹-269 Cr |
| Mar2023 | ₹-2,707 Cr |
| Mar2022 | ₹-2,195 Cr |
| Mar2021 | ₹75 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-804 Cr | Negative | |
| Mar2024 | ₹-269 Cr | Negative | |
| Mar2023 | ₹-2,707 Cr | Negative | |
| Mar2022 | ₹-2,195 Cr | Negative | |
| Mar2021 | ₹75 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹175,677.4 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 2.5% | 3.6% | -19.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 3.2% |
4.8% |
12.8% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses